| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Nov 19, 2024 | Buy(P) | 667K | $2.25 | $1.5M | 710K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-027348) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Aclaris Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.